Aviva PLC (OTCMKTS:AVVIY - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the five ratings firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and two have issued a strong buy recommendation on the company.
Several research firms recently weighed in on AVVIY. Citigroup upgraded Aviva to a "hold" rating in a research report on Tuesday. Barclays downgraded Aviva from a "strong-buy" rating to a "hold" rating in a research report on Monday, June 16th.
Get Our Latest Stock Analysis on AVVIY
Aviva Trading Up 0.2%
Shares of AVVIY stock traded up $0.04 on Monday, reaching $17.41. The stock had a trading volume of 23,477 shares, compared to its average volume of 35,496. Aviva has a 1 year low of $11.49 and a 1 year high of $17.47. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.86 and a current ratio of 1.86. The company has a 50 day simple moving average of $16.74 and a 200 day simple moving average of $14.64.
About Aviva
(
Get Free ReportAviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.
See Also
Before you consider Aviva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aviva wasn't on the list.
While Aviva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
